Gemcitabine Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Non-small Cell Lung Cancer 20.4%
Prophylaxis 11.4%
Pancreatic Carcinoma 9.8%
Breast Cancer Metastatic 8.2%
Hypertension 5.9%
Pain 5.9%
Nausea 5.0%
Constipation 4.5%
Breast Cancer 3.6%
Diffuse Large B-cell Lymphoma 3.4%
Pancreatic Carcinoma Non-resectable 3.3%
Transitional Cell Carcinoma 2.9%
Adenocarcinoma Pancreas 2.8%
Diabetes Mellitus 2.4%
Pancreatic Carcinoma Metastatic 2.1%
Bladder Cancer 1.9%
Bile Duct Cancer 1.7%
Premedication 1.6%
Prophylaxis Of Nausea And Vomiting 1.6%
Insomnia 1.5%
Pneumonia 10.5%
Thrombocytopenia 8.7%
Adverse Event 8.1%
Pulmonary Embolism 7.6%
Vomiting 7.6%
Pyrexia 7.0%
Death 6.8%
Hospitalisation 5.2%
Sepsis 5.0%
Neutropenia 4.3%
Renal Failure Acute 3.9%
Pleural Effusion 3.7%
Urinary Tract Infection 3.5%
Thrombotic Microangiopathy 2.9%
Deep Vein Thrombosis 2.7%
Weight Decreased 2.7%
Neutropenic Sepsis 2.5%
Platelet Count Decreased 2.5%
White Blood Cell Count Decreased 2.5%
Nausea 2.3%
Secondary
Non-small Cell Lung Cancer 29.8%
Drug Use For Unknown Indication 19.3%
Hypertension 6.3%
Prophylaxis 6.1%
Pancreatic Carcinoma 5.2%
Prophylaxis Of Nausea And Vomiting 4.6%
Pain 3.8%
Constipation 2.7%
Pancreatic Carcinoma Metastatic 2.4%
Abdominal Pain 2.2%
Breast Cancer Metastatic 2.2%
Nausea 2.1%
Transitional Cell Carcinoma 2.0%
Breast Cancer 1.7%
Diffuse Large B-cell Lymphoma 1.7%
Chest Pain 1.7%
Diarrhoea 1.7%
Thrombosis Prophylaxis 1.6%
Bladder Cancer 1.5%
Anaemia 1.4%
Thrombocytopenia 15.7%
Pyrexia 9.1%
Neutropenia 7.7%
Vomiting 7.7%
Pulmonary Embolism 7.5%
Weight Decreased 6.4%
Sepsis 4.6%
Pleural Effusion 4.4%
Deep Vein Thrombosis 4.0%
Pneumonia 4.0%
Thrombosis 4.0%
Platelet Count Decreased 3.5%
Death 3.3%
Wound Infection 3.3%
White Blood Cell Count Decreased 3.1%
Renal Failure Acute 2.9%
Dyspnoea 2.2%
Epistaxis 2.2%
General Physical Health Deterioration 2.2%
Haemoptysis 2.2%
Concomitant
Drug Use For Unknown Indication 22.6%
Product Used For Unknown Indication 13.4%
Breast Cancer 9.5%
Non-small Cell Lung Cancer 7.9%
Metastases To Bone 7.0%
Metastatic Renal Cell Carcinoma 6.0%
Breast Cancer Metastatic 4.7%
Pancreatic Carcinoma Metastatic 4.3%
Chemotherapy 3.0%
Adenocarcinoma Pancreas 2.9%
Ovarian Cancer 2.4%
Pancreatic Carcinoma 2.2%
Pleural Mesothelioma Malignant 2.2%
Nausea 2.0%
Anxiety 1.7%
Hiv Infection 1.7%
Lung Adenocarcinoma Metastatic 1.7%
Pain 1.7%
Pain In Jaw 1.6%
Anaemia Of Malignant Disease 1.4%
Stomatitis 7.8%
Vomiting 7.8%
Wound Infection Staphylococcal 7.8%
Thrombocytopenia 7.0%
Pneumonia 6.2%
Pyrexia 6.2%
Weight Decreased 5.4%
Rash 4.7%
Tachycardia 4.7%
Tooth Extraction 4.7%
Upper Respiratory Tract Infection 4.7%
Vision Blurred 4.7%
White Blood Cell Count Decreased 4.7%
X-ray Abnormal 4.7%
Death 3.9%
Pulmonary Embolism 3.9%
Septic Shock 3.1%
Sudden Death 3.1%
Wound Drainage 3.1%
Febrile Neutropenia 2.3%